Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China
· Delayed Price · Currency is CNY 30.78
+2.66 (9.46%)
Mar 10, 2026, 1:15 PM CST
SHE:300878 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,994 | 2,141 | 3,673 | 3,591 | 4,246 | 4,045 | Upgrade
|
| Market Cap Growth | 85.73% | -41.72% | 2.30% | -15.42% | 4.95% | - | Upgrade
|
| Enterprise Value | 4,013 | 2,172 | 3,685 | 3,506 | 3,996 | 3,413 | Upgrade
|
| Last Close Price | 28.12 | 14.94 | 24.77 | 24.21 | 28.27 | 26.37 | Upgrade
|
| PE Ratio | - | - | - | 73.57 | 44.00 | 29.79 | Upgrade
|
| PS Ratio | 30.34 | 6.10 | 7.07 | 6.74 | 6.71 | 6.50 | Upgrade
|
| PB Ratio | 3.88 | 1.82 | 2.61 | 2.55 | 3.01 | 2.92 | Upgrade
|
| P/TBV Ratio | 4.11 | 1.92 | 2.77 | 2.69 | 3.17 | 2.99 | Upgrade
|
| P/OCF Ratio | 78.27 | - | 63.02 | 24.73 | - | 94.49 | Upgrade
|
| EV/Sales Ratio | 30.48 | 6.19 | 7.09 | 6.58 | 6.31 | 5.48 | Upgrade
|
| EV/EBITDA Ratio | - | - | 137.76 | 41.71 | 40.93 | 25.29 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 64.63 | 47.80 | 27.79 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.25 | 0.31 | 0.23 | 0.06 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 16.27 | 3.30 | 0.74 | 0.11 | Upgrade
|
| Net Debt / Equity Ratio | 0.00 | 0.03 | -0.10 | 0.11 | -0.14 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.02 | -0.37 | -5.25 | 1.86 | -2.03 | -4.30 | Upgrade
|
| Net Debt / FCF Ratio | -0.37 | -0.25 | 1.73 | -5.54 | 0.83 | 5.30 | Upgrade
|
| Asset Turnover | 0.08 | 0.19 | 0.26 | 0.30 | 0.38 | 0.50 | Upgrade
|
| Inventory Turnover | 1.62 | 1.64 | 1.91 | 1.78 | 1.93 | 2.40 | Upgrade
|
| Quick Ratio | 1.84 | 1.96 | 1.95 | 2.09 | 2.98 | 4.20 | Upgrade
|
| Current Ratio | 2.34 | 2.57 | 2.36 | 2.50 | 3.74 | 4.67 | Upgrade
|
| Return on Equity (ROE) | -26.31% | -11.22% | -0.50% | 3.51% | 6.91% | 14.25% | Upgrade
|
| Return on Assets (ROA) | -7.46% | -5.44% | -0.63% | 1.88% | 3.15% | 6.13% | Upgrade
|
| Return on Invested Capital (ROIC) | -18.75% | -13.03% | -1.40% | 3.06% | 8.01% | 15.82% | Upgrade
|
| Return on Capital Employed (ROCE) | -15.70% | -11.40% | -1.20% | 3.60% | 5.70% | 8.70% | Upgrade
|
| Earnings Yield | -7.90% | -6.89% | -0.24% | 1.36% | 2.27% | 3.36% | Upgrade
|
| FCF Yield | -0.19% | -7.20% | -2.21% | -0.79% | -5.63% | -2.71% | Upgrade
|
| Dividend Yield | 0.49% | 0.94% | 1.01% | - | 1.06% | 2.11% | Upgrade
|
| Payout Ratio | - | - | - | 93.71% | 83.93% | 5.77% | Upgrade
|
| Buyback Yield / Dilution | 4.22% | 4.09% | -3.96% | 0.32% | -19.60% | -10.96% | Upgrade
|
| Total Shareholder Return | 4.72% | 5.03% | -2.95% | 0.32% | -18.53% | -8.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.